InnovAge Holding Corp
NASDAQ:INNV
Intrinsic Value
InnovAge Holding Corp. engages in the provision of a healthcare delivery platform. [ Read More ]
The intrinsic value of one INNV stock under the Base Case scenario is 6.08 USD. Compared to the current market price of 3.99 USD, InnovAge Holding Corp is Undervalued by 34%.
Valuation Backtest
InnovAge Holding Corp
Run backtest to discover the historical profit from buying and selling INNV stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
InnovAge Holding Corp
Current Assets | 157m |
Cash & Short-Term Investments | 98.8m |
Receivables | 43.7m |
Other Current Assets | 14.5m |
Non-Current Assets | 377.3m |
Long-Term Investments | 3.6m |
PP&E | 222.1m |
Intangibles | 146.4m |
Other Non-Current Assets | 5.2m |
Current Liabilities | 123.1m |
Accounts Payable | 52.4m |
Accrued Liabilities | 3.7m |
Other Current Liabilities | 67m |
Non-Current Liabilities | 125.6m |
Long-Term Debt | 74.5m |
Other Non-Current Liabilities | 51.2m |
Earnings Waterfall
InnovAge Holding Corp
Revenue
|
720.8m
USD
|
Cost of Revenue
|
-602m
USD
|
Gross Profit
|
118.8m
USD
|
Operating Expenses
|
-150.4m
USD
|
Operating Income
|
-31.6m
USD
|
Other Expenses
|
38k
USD
|
Net Income
|
-31.5m
USD
|
Free Cash Flow Analysis
InnovAge Holding Corp
INNV Profitability Score
Profitability Due Diligence
InnovAge Holding Corp's profitability score is 38/100. The higher the profitability score, the more profitable the company is.
Score
InnovAge Holding Corp's profitability score is 38/100. The higher the profitability score, the more profitable the company is.
INNV Solvency Score
Solvency Due Diligence
InnovAge Holding Corp's solvency score is 50/100. The higher the solvency score, the more solvent the company is.
Score
InnovAge Holding Corp's solvency score is 50/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
INNV Price Targets Summary
InnovAge Holding Corp
According to Wall Street analysts, the average 1-year price target for INNV is 6.89 USD with a low forecast of 6.57 USD and a high forecast of 7.35 USD.
Ownership
INNV Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Shareholder Return
INNV Price
InnovAge Holding Corp
Average Annual Return | -17.5% |
Standard Deviation of Annual Returns | 87.41% |
Max Drawdown | -87% |
Market Capitalization | 542.2m USD |
Shares Outstanding | 135 899 008 |
Percentage of Shares Shorted | 1.9% |
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
InnovAge Holding Corp. engages in the provision of a healthcare delivery platform. The company is headquartered in Denver, Colorado and currently employs 1,800 full-time employees. The company went IPO on 2021-03-04. The firm delivers its patient-centered care through the InnovAge Platform. InnovAge Platform is focused on frail, dual-eligible seniors, and it serve participants primarily through Program of All-inclusive Care for the Elderly (PACE). InnovAge Platform provides complete, coordinated healthcare to enable its frail, nursing home-eligible seniors to live independently in their homes and communities. The InnovAge Platform consists of Interdisciplinary Care Teams and community-based care delivery model. The firm's subsidiaries include TCO Intermediate Holdings, Inc., Total Community Options, Inc., InnovAge Investment Holdings, LLC, TCO Eastern Holdings, LLC, InnovAge Pennsylvania LIFE, LLC, InnovAge Virginia PACE Roanoke Valley, LLC, InnovAge Virginia PACE II, LLC, InnovAge Virginia PACE Charlottesville, LLC, Total Longterm Care Solutions, LLC, Total Longterm Care, Inc. and InnovAge Greater Colorado PACE-Loveland, LLC.
Contact
IPO
Employees
Officers
The intrinsic value of one INNV stock under the Base Case scenario is 6.08 USD.
Compared to the current market price of 3.99 USD, InnovAge Holding Corp is Undervalued by 34%.